Research in the area of controlled drug release is increasingly important in the pharmaceutical industry both from quality of life and commercial perspectives. One form of controlled release is of active components incorporated in solid polymer matrices. Understanding the nature and control of drug release is focal to the effective control and targeting of drugs. This will allow the prediction and modelling of new delivery systems. The aim of this thesis is to determine the principal manufacturing parameters affecting the release of a soluble drug from a non-swelling polymer matrix and so to understand better the dissolution mechanism. The matrix chosen for study is Eudragit and the chosen drug is Diltiazem Hydrochloride. Magnetic Resonance...
Cellulose ethers have been increasingly used in the formulation of controlled release dosage forms; ...
An attempt was made in this study to relate the release of a highly water-soluble model drug from ta...
Hydrophylic matrix tablets containing polyethylene oxides as the retarding polymer has been succesfu...
Important current developments in pharmaceutical science are in the area of formulation technology ...
This study focuses on the physical and chemical properties of the matrix controlled release (MCR) de...
Extensive studies of extended release tablets based on hydrophilic polymers have illuminated several...
Extensive studies of extended release tablets based on hydrophilic polymers have illuminated several...
Tablets exhibiting extended drug release have in many therapeutical applications shown both complian...
Tablets exhibiting extended drug release have in many therapeutical applications shown both complian...
In this paper a new model describing drug release from a polymer matrix tablet is presented. The uti...
In this paper a new model describing drug release from a polymer matrix tablet is presented. The uti...
We have investigated the dissolution performance of amorphous solid dispersions of poorly water-solu...
In this paper a new model describing drug release from a polymer matrix tablet is presented. The uti...
We have investigated the dissolution performance of amorphous solid dispersions of poorly water-solu...
Eudragit® NM was investigated as a matrix former in combination with microcrystalline cellulose as a...
Cellulose ethers have been increasingly used in the formulation of controlled release dosage forms; ...
An attempt was made in this study to relate the release of a highly water-soluble model drug from ta...
Hydrophylic matrix tablets containing polyethylene oxides as the retarding polymer has been succesfu...
Important current developments in pharmaceutical science are in the area of formulation technology ...
This study focuses on the physical and chemical properties of the matrix controlled release (MCR) de...
Extensive studies of extended release tablets based on hydrophilic polymers have illuminated several...
Extensive studies of extended release tablets based on hydrophilic polymers have illuminated several...
Tablets exhibiting extended drug release have in many therapeutical applications shown both complian...
Tablets exhibiting extended drug release have in many therapeutical applications shown both complian...
In this paper a new model describing drug release from a polymer matrix tablet is presented. The uti...
In this paper a new model describing drug release from a polymer matrix tablet is presented. The uti...
We have investigated the dissolution performance of amorphous solid dispersions of poorly water-solu...
In this paper a new model describing drug release from a polymer matrix tablet is presented. The uti...
We have investigated the dissolution performance of amorphous solid dispersions of poorly water-solu...
Eudragit® NM was investigated as a matrix former in combination with microcrystalline cellulose as a...
Cellulose ethers have been increasingly used in the formulation of controlled release dosage forms; ...
An attempt was made in this study to relate the release of a highly water-soluble model drug from ta...
Hydrophylic matrix tablets containing polyethylene oxides as the retarding polymer has been succesfu...